Cournoyer et al. found that CD133-positive cells isolated from six NB cell lines have gains on 16p13.3, 19p13.3, and 19q13.33 that are on the contrary absent in CD133-negative cells. This evidence concerns the gene PROM1 and neuroblastoma.